Workflow
赣锋锂业:徐建章获选举为独立非执行董事
Zhi Tong Cai Jing· 2026-03-23 14:39
Core Viewpoint - Ganfeng Lithium (01772) announced the resignation of Ms. Xu Yixin as an independent non-executive director and proposed the appointment of Mr. Xu Jianzhang as an independent non-executive director, effective from March 23, 2026 [1] Group 1 - Ms. Xu Yixin's resignation is due to the expiration of her term, and Mr. Xu Jianzhang has been elected as an independent non-executive director at the extraordinary general meeting scheduled for March 11, 2026 [1] - Following Ms. Xu Yixin's resignation, Mr. Xu Jianzhang will also assume the role of chairman of the board's remuneration and assessment committee, effective from March 23, 2026 [1] - Mr. Xu Guanghua, who has served as an independent non-executive director since March 24, 2020, will also resign on March 23, 2026, after completing his six-year term [1]
中国农业银行双河兵团分行被罚27.6万元:违反支付结算管理规定等
Xin Lang Cai Jing· 2026-03-23 13:59
Core Viewpoint - The Agricultural Bank of China, Shuanghe Corps Branch, has been penalized for violating payment settlement management regulations, anti-counterfeiting currency regulations, and anti-money laundering regulations, resulting in a warning and a fine of 276,000 RMB [1][4]. Group 1 - The Agricultural Bank of China, Shuanghe Corps Branch, received a warning and a fine of 276,000 RMB for multiple regulatory violations [1][4]. - The violations include breaches of payment settlement management regulations, anti-counterfeiting currency regulations, and anti-money laundering regulations [1][3][6]. - The administrative penalty was issued by the People's Bank of China, Bortala Mongol Autonomous Prefecture Branch, on March 17, 2026, with a public disclosure period of three years [3][6].
福耀玻璃(03606.HK)获Mitsubishi UFJ Financial Group增持81.76万股
Ge Long Hui· 2026-03-23 13:44
Group 1 - Mitsubishi UFJ Financial Group, Inc. increased its stake in Fuyao Glass (03606.HK) by purchasing 817,600 shares at an average price of HKD 60.7035 per share, totaling approximately HKD 49.6312 million [1] - Following the acquisition, Mitsubishi UFJ's total holdings in Fuyao Glass rose to 37,218,400 shares, increasing its ownership percentage from 5.99% to 6.13% [1]
建设银行信用卡中心被罚没575万元,涉未按规定退还分期利息等14项违规
Xin Lang Cai Jing· 2026-03-23 13:31
Core Viewpoint - The China Construction Bank Credit Card Center has been fined over 5.85 million yuan for multiple violations of prudent operational rules, highlighting significant regulatory scrutiny in the credit card industry [1][5][6]. Summary by Category Regulatory Actions - The Shanghai Regulatory Bureau of the National Financial Supervision Administration imposed a total fine of 5.75265 million yuan on the China Construction Bank Credit Card Center for various violations [1][6]. - Two deputy directors of the risk management department were fined 50,000 yuan each for their roles in the violations [8]. Violations Identified - Major violations include: 1. Serious breaches in customer creditworthiness investigations 2. Serious breaches in credit limit management 3. Serious breaches in credit card installment fund management 4. Serious breaches in credit card overdraft fund management 5. Failure to take prudent regulatory measures for high-risk cardholders 6. Issuing credit loans to related parties 7. Engaging in credit card marketing activities without qualification 8. Serious breaches in credit card issuance 9. Serious breaches in cash advance installment business 10. Serious breaches in suspicious transaction account management 11. Failure to refund installment interest as required 12. Serious breaches in card issuance business management 13. Serious breaches in outsourced credit card collection management 14. Inadequate management of merchant access [1][5][8]. Industry Context - The China Construction Bank Credit Card Center was established on January 22, 2009, and is located in the China (Shanghai) Pilot Free Trade Zone [3][8]. - In the past year, several other institutions, including the Postal Savings Bank of China and Huaxia Bank, have also faced penalties for various compliance issues, indicating a broader trend of regulatory enforcement in the credit card sector [4][9].
工商银行董事长廖林:助力企业在不确定不稳定国际环境中抵御风险
Xin Lang Cai Jing· 2026-03-23 13:20
Core Viewpoint - The chairman of Industrial and Commercial Bank of China (ICBC), Liao Lin, emphasized the bank's commitment to implementing the national "14th Five-Year Plan" and enhancing global integration to support China's high-level opening-up [1] Group 1: Strategic Initiatives - ICBC aims to create comprehensive financial solutions centered around customer needs, promoting the integration of capital, trade, and information chains [1] - The bank will leverage platforms such as the BRICS Business Council, China-Europe Business Alliance, and the "Belt and Road" interbank cooperation mechanism to help domestic and international enterprises create new markets [1] Group 2: Risk Management and Stability - ICBC is focused on strengthening its comprehensive risk management system to build a solid safety net [1] - The bank plans to empower clients through its intelligent risk control platform, assisting enterprises in navigating uncertainties in the international environment and maintaining the stability and security of global supply chains [1]
富瑞:中国中免销售趋势复苏 评级“持有”目标价61.7港元
Zhi Tong Cai Jing· 2026-03-23 13:01
Core Viewpoint - China Duty Free Group (中国中免) is expected to report a net profit for Q4 2025 that exceeds market expectations by 23% and the firm's estimates by 5%, while revenue is projected to be 3% above market expectations but 5% below the firm's estimates [2] Group 1: Financial Performance - The anticipated net profit for Q4 2025 is significantly higher than market expectations, indicating strong financial performance [2] - Revenue projections show a slight discrepancy, being above market expectations but below the firm's estimates, suggesting mixed performance in revenue generation [2] Group 2: Market Trends - Sales trends have shown signs of recovery since the full island closure in Hainan on December 18, indicating a positive shift in consumer behavior [2] - The focus of the market will be on sales forecasts post-Hainan's closure, highlighting the importance of this region for the company's performance [2] Group 3: Strategic Developments - The transition from a 51% stake in Sunrise China to fully owning the port duty-free business is a significant strategic move for the company [2] - The opening of the new Taikoo Place in 2026 is expected to be a key event for the company, potentially impacting future sales and market presence [2]
资金风向标 | 比亚迪获资金净流入13.59亿元
Core Viewpoint - The article highlights the top ten stocks with the highest net inflow of funds on March 23, with BYD leading the list with a net inflow of 1.359 billion yuan [1]. Group 1: Top Stocks by Net Inflow - BYD (002594.SZ) received a net inflow of 1.359 billion yuan [2]. - Xiexin Integrated (002506.SZ) followed closely with a net inflow of 1.354 billion yuan [2]. - Shunhao Co., Ltd. (002565.SZ) had a net inflow of 1.155 billion yuan [2]. - Jinfat Technology (600143.SH) recorded a net inflow of 722 million yuan [2]. - Wolong Electric Drive (600580.SH) saw a net inflow of 708 million yuan [2]. - Tuojin New Energy (002218.SZ) had a net inflow of 583 million yuan [2]. - Haima Automobile (000572.SZ) experienced a net inflow of 473 million yuan [2]. - China Shenhua (601088.SH) recorded a net inflow of 469 million yuan [2]. - Yinzhi Jie (300085.SZ) had a net inflow of 450 million yuan [2]. - Huamin Co., Ltd. (300345.SZ) saw a net inflow of 433 million yuan [2].
【中国银河固收】转债周报 | 短期尚未企稳,待中期转机
Xin Lang Cai Jing· 2026-03-23 12:45
Core Viewpoint - The equity market is under pressure due to ongoing geopolitical conflicts, tightening global liquidity expectations, and high oil prices, leading to a decline in risk appetite for equity assets [1][18] Weekly Review of Convertible Bond Market - During the week of March 16-20, the Shanghai Composite Index fell 3.38% to 3957.1 points, while the China Convertible Bond Index dropped 3.15% to 492.6 points [1][5] - Major indices experienced more declines than gains, with only the ChiNext Index rising by 1.3% [1][5] - The trading volume in the convertible bond market decreased, with the total daily trading volume for the entire A-share market falling by 11.5% to 2.21 trillion yuan [10][11] Market Outlook - The current adjustment in the convertible bond market may continue for another 20-50 days, with a potential decline of 10%-20% expected [2][19] - The People's Bank of China has indicated a commitment to maintaining stability in financial markets, which may provide liquidity support to the equity market [2][19] - The focus is shifting towards fundamental pricing as the market approaches the annual report disclosure period, with physical assets being favored over virtual assets [3][25] Sector Performance - The majority of sectors saw declines, with only the telecommunications and banking sectors showing positive performance [1][7] - Convertible bonds across all sectors fell, with financial convertible bonds showing relative resilience [1][7] Trading Activity - The number of convertible bonds subject to forced redemption decreased, with four bonds totaling 1.061 billion yuan announced for forced redemption, down by 2.852 billion yuan from the previous week [15][26] - The average price of convertible bonds fell by 5.69 yuan to 101.92 yuan, indicating a continued decline in valuation [10][11] Investment Strategy - Investors are advised to maintain strict control over positions and focus on low-priced convertible bonds for defensive strategies [3][25] - There may be opportunities for rebound in strong stocks during market fluctuations, with a cautious approach recommended for speculative participation [3][25]
新华制药:关于子公司获得布洛芬颗粒药品注册证书的公告
Zheng Quan Ri Bao· 2026-03-23 12:40
Group 1 - The core point of the article is that Xinhua Pharmaceutical has received approval for its Ibuprofen granules from the National Medical Products Administration [2] Group 2 - The approval was granted to Shandong Zibo Xinda Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Xinhua Pharmaceutical [2] - The issuance of the drug registration certificate marks a significant milestone for the company in expanding its product offerings [2]
荣昌生物维迪西妥单抗用于治疗HER2低表达且存在肝转移的乳腺癌适应症上市申请获得批准
Bei Jing Shang Bao· 2026-03-23 12:37
Core Viewpoint - Rongchang Biopharmaceutical (688331) has received approval from the National Medical Products Administration for the new indication of Vedisizumab (brand name: Aidiqi) to treat HER2 low-expressing breast cancer with liver metastasis, marking the fourth approved indication for this drug in China [1] Group 1 - The approval of the new indication enhances the market competitiveness of Vedisizumab [1]